Mergers & Acquisitions


Current filters:


Popular Filters

770 to 794 of 914 results

AbbVie selected as name for Abbott research-based spin out


Confirming its previous announcements on plans to split the US health care major, Abbott Laboratories…

Abbott LaboratoriesAbbVieMergers & AcquisitionsPharmaceutical

Synergy Health buys only Swiss gamma and X-ray irradiation facility


UK-based Synergy Health (LSE: SYR), a provider of outsourced sterilization services to the medical device…

Leoni StuderMergers & AcquisitionsPharmaceuticalSynergy Health

Flamel Tech acquires US firm Eclat Pharma; reports loss


Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Grifols acquires 51% stake in Araclon Biotech


Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Sanofi expands in biosurgery, buying Pluromed


French drug major Sanofi (Euronext: SAN) said on Friday that it is to acquire Pluromed, a USA-based medical…

Mergers & AcquisitionsPharmaceuticalPluromedSanofi

Shire to acquire FerroKin BioSciences; drops Replagal BLA


Ireland-headquartered Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire privately-held…

FerroKin BioSciencesMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalRare diseasesRegulationReplagalShire

GlaxoSmithKline off loads more OTC brands


Following its earlier announcement that it intends to divest non-core Consumer Healthcare over-the-counter…

GlaxoSmithKlineMergers & AcquisitionsOmega PharmaPharmaceutical

Valeant goes shopping again, buying branded generics from Gerot Lannach


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

AspirinGenericsGerot LannachMergers & AcquisitionsValeant Pharmaceuticals

Prestige Brands rejects hostile bid from Mexican drugmaker


US OTC and household products company Prestige Brands Holdings (NYSE: PBH) has turned down an $834 million…

Genomma LabMergers & AcquisitionsPharmaceuticalPrestige Brands

Valeant on acquisition trail again


In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsPele Nova BiotecnologiaPharmaceuticalRegedermSouth AmericaValeant Pharmaceuticals

Roche has options beyond Illumina


Speaking at the companys annual meeting, Swiss drug maj'or Roche (ROG: SIX) chairman Franz Humer said:…

FinancialIlluminaMergers & AcquisitionsPharmaceuticalRoche

Abcam to buy Epitomics for $170 million


In a second acquisition within six months, UK-based protein research tools supplier Abcam (AIM: ABC)…

AbcamEpitomics InternationalFinancialMergers & AcquisitionsPharmaceutical

Amgen says tender offer for Micromet on track


Global biotech leader Amgen (Nasdaq: AMGN) says that all conditions to the closing of the tender offer…

AmgenBiotechnologyMergers & AcquisitionsMicromet

Abbott unit snaps up LIMS distributors


As part of a series of strategic moves to build its laboratory information management system (LIMS) business…

Abbott LaboratoriesMergers & AcquisitionsPharmaceuticalSTARLIMS

GSK and Daiichi Sankyo set up Japanese vaccines JV


UK pharma giant GlaxoSmithKline (LSE: GSK) says it has signed an agreement with Japan's third-largest…

Asia-PacificDaiichi SankyoGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalVaccines

Dompe to acquire 100% control of Anabasis


Italian biopharmaceutical firm Dompe has entered into a definitive agreement to acquire 100% of Anabasis…

BiotechnologyMergers & AcquisitionsOphthalmics

Bayer still aims for top-10 position in Pharma


Germany's Bayer (BAY: DE) is still confident that it can become a top-10 gobal pharmaceutical company,…

Markets & MarketingMergers & AcquisitionsPharmaceuticalResearch

Dainippon Sumitomo to acquire Boston Biomedical


Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) says it has reached an agreement for the acquisition…

BiotechnologyMergers & AcquisitionsOncologyPharmaceutical

Lundbeck buys remaining rights to desmoteplase from Paion


Danish CNS drug specialist Lundbeck A/S (LUND: DC) and Germany’s Paion AG (FSE: PA8) have entered…

Cardio-vasculardesmoteplaseLundbeckMergers & AcquisitionsPaionPharmaceutical

Roche extends Illumina takeover deadline


Roche has extended its $5.7 billion hostile takeover offer for genetic sequencing specialist Illumina…

HomeIlluminaMergers & AcquisitionsPharmaceuticalRoche

Herborium signs Lol to be acquired by China Health Resource


New Jersey, USA-based botanical therapeutics company Herborium (Pink Sheets: HBRM) says it has signed…

China Health ResourceHerboriumMergers & AcquisitionsPharmaceutical

770 to 794 of 914 results

Company Spotlight



Back to top